Skip to main content
Submitted by PatientsEngage on 28 March 2022

This webinar is not just for Ovarian Cancer survivors but also for survivors of breast cancer, uterine cancer, colorectal cancer and all women at risk of Ovarian Cancer.

Ovarian Cancer is a difficult to diagnose cancer. So it is very important for us to be aware of the surprising symptoms of Ovarian cancer. We must also know the factors that increase risk.
Additionally, in COVID times, it is important to understand how to continue treatment and when you should vaccinate.

We bring together a panel of
Dr. Shyam Aggarwal, Chairman Medical Oncology, Sir Gangaram Hospital, New Delhi
Dr. Nidhi Tandon, Consultant Medical Oncology Narayana Health, Bengaluru
Dr. Vivek Agarwala, Medical Oncologist, Narayana Superspeciality Hospital, Kolkata

In the video (recording link below) we talk about:

  • What is ovarian cancer and who is at risk of ovarian cancer? is it hereditary
  • What are the early signs or symptoms of ovarian cancer?
  • Who should you consult when you have symptoms
  • What is the difference between cyst and cancer and how to differentiate between the two
  • Does removal of ovaries reduce lifespan?
  • What are the treatment options after diagnosis of ovarian cancer?
  • What risks should patients be aware of and role of chemo before or after surgery
  • If you have ovarian cancer can you also get breast cancer?
  • Even during covid cancer treatment cannot be postponed
  • Are video consults useful
  • Can cancer patients undergo Covid vaccination

 

Stories

  • 3 As for Breast Cancer Recovery
    Plus other tips that got me through. A breast cancer survivor from Delhi shares. Diet 3As - Apple, Anar (pomegranate), Amla (gooseberry) Wheatgrass (if you can manage) Broccoli Do not eat fried and fatty food  If you go out once in a while, eat without making a fuss - so you don't get isolated Eat even if you don't feel like it Mental wellbeing Read The Secret by Rhonda Byrne Make a list of things you want to do - think forward into the future (even a child's wedding) Physical…
  • Red meat consumption in young women increases breast cancer risk
    In conclusion, higher consumption of red meat during adolescence was associated with premenopausal breast cancer. Substituting other dietary protein sources for red meat in adolescent diet may decrease premenopausal breast cancer risk. The breast is particularly vulnerable to carcinogenic influences during adolescence due to rapid proliferation of mammary cells and lack of terminal differentiation. We investigated consumption of adolescent red meat and other protein sources in relation to…
  • Mind over body...
    Minakshi Ray on her battle with breast cancer and what it took to win.  “Life is like a game in the boxing ring. Defeat is not declared till you refuse to get up” The line pretty much defines me – I am generally known as a very positive person among my friends and family and staunchly believe that the Almighty helps those who decide to help themselves! On a cold January morning last year, the doctor handed over the biopsy report of the breast lump to my husband with a little…
  • Inflammation
    Inflammation has been linked to a slew of diseases – from allergies to cancer, heart trouble, bowel problems and diabetes. What is it and how can we protect ourselves. - By paediatrician and family practitioner Dr Gita Mathai. What is inflammation? The word is derived from the Latin “inflammo” meaning ignite or set alight. It conjures up visions of fire, and it is the body’s response to an injury, like a broken bone, a scrape in the skin or an infection by an organism (…
  • Parents deny girls cancer treatment, say doctors
    Cancer Institute chairperson Dr V Shanta expressed concern over underreporting of cancer among children, especially in rural areas. Advances in oncology over the past six decades have ensured that up to 75 % of all paediatric cancers can be cured. While it is possible to treat all pediatric cases in the country, there is a need to increase affordability and accessibility for the same," she said. http://timesofindia.indiatimes.com/City/Chennai/Parents-deny-girls-cancer-treatment-say-doctors…
  • Chemotherapy explained in Hindi
    Do not fear Chemotherapy ! Understand Chemotherapy and how to deal with it. A great video in Hindi by SanjeevaniLifeBeyondCancer  
  • Novel Immunotherapy Vaccine Decreases Recurrence in HER2 Breast Cancer Patients
    Women with breast cancer tumors that overexpress human epidermal growth factor receptor 2 (HER2) may benefit from a novel vaccine to prevent recurrence A new breast cancer vaccine candidate, (GP2), provides further evidence of the potential of immunotherapy in preventing disease recurrence. One of only a few vaccines of its kind in development, GP2 has been shown to be safe and effective for breast cancer patients, reducing recurrence rates by 57%. Further, women with the highest overexpression…
  • My cancer doesn't define who I am
    "I was originally diagnosed with locally advanced cancer, so that means it's advanced within in the chest. Mine was triple negative. It's the most aggressive form of cancer," she said. Her breast cancer diagnosis came in 2008. She found out about her metastatic breast cancer in January 2011, at 33 years old. "Two and half years after my original diagnosis, I found another lump," she said as she held back tears. "It varies from person to person. But my experience has been a bit of a roller…
  • Joan Lunden talks about her Breast Cancer
    How she shared the information with her kids and why - http://www.today.com/health/joan-lunden-how-i-told-my-kids-i-have-cancer-2D80186889 The choices she made in terms of treatment - http://www.people.com/article/joan-lunden-chemotherapy-cancer
  • Breast cancer drug Perjeta appears to extend patients lives
    According to reports from clinical trials, Roche’s breast cancer drug Perjeta displays “unprecedented” life-extending effects, helping patients live an average of 15.7 months longer than they would on chemotherapy and an older drug. 15.7 months is a significant amount of time for metastatic breast cancer patients, who are, on average, given two to three years to live after their diagnosis. Perjeta, then, has the capacity to increase that time by 50 to 75 percent.  http://www…